Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000582001 | SCV000687084 | likely benign | Hereditary cancer-predisposing syndrome | 2017-07-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000582001 | SCV001187479 | likely benign | Hereditary cancer-predisposing syndrome | 2018-12-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV004562596 | SCV004364429 | likely benign | Familial adenomatous polyposis 1 | 2023-12-27 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004562596 | SCV005083347 | benign | Familial adenomatous polyposis 1 | 2024-04-04 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
All of Us Research Program, |
RCV004807008 | SCV005427655 | likely benign | Classic or attenuated familial adenomatous polyposis | 2024-08-29 | criteria provided, single submitter | clinical testing |